Coronavirus disease 2019

condividi

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Ti potrebbe interessare

Nuovo Prodotto Lilianails

TIXO SOUFFLÉ GEL
Siamo entusiasti di presentare il nuovo gioiello della nostra linea di prodotti LiliaNails: il Tixo Soufflé Gel Un gel costruttore che supera ogni aspettativa: tissotropico, elastico e dalla consistenza soffice e delicata come un soufflé! Una delle caratteristiche più sorprendenti del Tixo Soufflé Gel è la sua bassa reazione esotermica, che significa che rimane saldamente al suo posto durante la lavorazione. Questo garantisce risultati impeccabili in ogni applicazione, consentendo di creare opere d’arte sulle unghie senza preoccuparsi di movimenti indesiderati. Ideale per le ricostruzioni, le coperture e gli allungamenti del letto ungueale, ma è anche estremamente versatile grazie alle sue incredibili opzioni di colore.

Cerca

Scrivi qui il prodotto che stai cercando